Eduard Gallardo has been appointed group leader of the U762 CIBERER at the Hospital de Sant Pau in Barcelona to replace Isabel Illa. This research team is specialized in neuromuscular diseases.
Dr. Gallardo has been working since 1993 in the field of non-immune neuropathies, myasthenia, inflammatory myopathies and muscular dystrophies, and more specifically in dysferlinopathies. He has more than 100 publications (PubMed) in the field of neuromuscular diseases and has been principal investigator of 12 research projects.
The research carried out at the U762 CIBERER-Neuromuscular Diseases Unit of the Hospital de Sant Pau is clearly translational, which has made it possible to derive multiple diagnostic techniques that have been incorporated into the portfolio of laboratory tests at this center. hospitable.
All these achievements in the laboratory, together with the work of excellence of the clinic of the Neuromuscular Diseases Unit of the Hospital de Sant Pau led by Isabel Illa, have led the group to be considered a unit of excellence in Spain (CSUR), in Catalonia. (UEC) and in Europe (ERN).